Orega Biotech Competitors and Similar CompaniesClear all

Orega Biotech's competitors and similar companies include VCANBIO and Spur Therapeutics.
Orega Biotech
Orega Biotech
Orega Biotech is a company that specializes in the discovery and development of monoclonal antibodies for cancer immunotherapy.
VCANBIO
VCANBIO
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
Spur Therapeutics
Spur Therapeutics
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
Founding Date
Founding Date
2010
Founding Date
1993
Founding Date
2015
Type
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Écully, FR HQ
Montpellier, FR
Montpellier, FR
Locations
Tianjin, CN HQ
Locations
Stevenage, GB HQ
Boston, US
New York, US
Employees
Employees
717% increase
Employees
2,0149% decrease
Employees
122

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥1.4b (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
¥438.8m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥993.4m (FY, 2025)
Gross profit
$8.9m (FY, 2022)
Net income
Net income
N/A
Net income
¥103.5m (FY, 2025)
Net income
($89m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 3.7m
Total funding raised
N/A
Total funding raised
$ 289.3m
For sources of this data, please see the company profile

View Company Profiles

VCANBIO
HQ
Tianjin, CN
Employees
2,014↓ 9% decrease

VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.

View company
Spur Therapeutics
HQ
Stevenage, GB

Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.

View company